About Argenx Se - ADR (ARGX)
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama ... Read more
- USD399.55
- USD400.61
- USD381.99
- 277.98k
Stock News
1 hour ago
Building on Greatness: Redesigned Toyota Camry Goes All-Hybrid at Kentucky Plant
Yahoo
1 hour ago
Accel Entertainment Announces Q1 2024 Operating Results
Yahoo
2 hours ago
Hennessy Advisors, Inc. Reports 25% Increase in Quarterly Earnings Per Share and Announces Quarterly Dividend
Yahoo
2 hours ago
UGI Corporation Announces Final Remarketing Period for its Series A Cumulative Perpetual Convertible Preferred Stock Relating to its 2021 Equity Units Offering
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
